Cheap Diabetes and Lung Medicine Deals Show Up on TrumpRx

TrumpRx, the discount program launched in January to curb prescription costs, has just expanded its catalog with three new drugs:

• Jentadueto – for type 2 diabetes
• Jentadueto XR – extended‑release version of Jentadueto
• Striverdi Respimat – for chronic obstructive pulmonary disease (COPD)

All three come from the German pharmaceutical company Boehringer Ingelheim.

Dramatic Price Drops

Even though a generic version of Jentadueto already sells for $25–$35 at pharmacies, the TrumpRx price remains competitive.

Program Limitations

• Cash‑only: Discounts apply only when patients pay cash; they cannot be combined with insurance.
• No impact on deductibles: The discount does not affect insurance coverage or deductibles.
• Experts view TrumpRx as a small tool rather than a comprehensive fix for high drug prices.

Current Reach and Usage

• The site lists fewer than 60 brand‑name drugs, many of which already have cheaper generic alternatives.
• Similar savings are available on other discount sites, and it is unclear how many people actually use TrumpRx.
• A recent survey found:
• Only about 1 in 3 prescription users have heard of the program.
• Just 7 % have checked its prices.
• Among those on GLP‑1 diabetes drugs, about 16 % reported looking at TrumpRx.

Broader Context

Despite these options, many Americans still face cost barriers. A recent poll showed that a third of adults had to cut back or skip medications in the past year to afford health care. The White House has not released usage statistics for TrumpRx since it opened, leaving its real impact uncertain.